News Industry News Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott October 09, 2019
News Conference News TCT 2019 IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI Caitlin E. Cox October 08, 2019
News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019
News Daily News FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD L.A. McKeown June 20, 2019
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Industry News EFFPAC RCT 24-month has revealed in EuroPCR 2019 that Luminor DCB demonstrate a non-increase of risk of death at 24-month follow-up May 23, 2019
News Industry News Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES May 23, 2019
News Conference News EuroPCR 2019 EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal L.A. McKeown May 23, 2019
News Conference News EuroPCR 2019 Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers Caitlin E. Cox May 23, 2019
News Conference News EuroPCR 2019 Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years Caitlin E. Cox May 21, 2019
News Daily News Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure? Yael L. Maxwell May 15, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Daily News A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex L.A. McKeown March 01, 2019
News Daily News Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis Todd Neale January 15, 2019
News Daily News REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months L.A. McKeown February 11, 2018